Table 1.
Clinical characteristics and analysis of influencing factors for prolonged jaundice.
| Clinical characteristics | Prolonged jaundice (n = 175) | Control (n = 149) | P-value | Adjusted OR (95% CI) | P-value |
|---|---|---|---|---|---|
| Sex | |||||
| Male | 110 (62.9) | 78 (52.3) | 0.056 | reference | NA |
| Female | 65 (37.1) | 71 (47.7) | 0.57 (0.34–0.98) | 0.560 | |
| Gestational age (weeks) | 38.72 ± 1.37 | 39.00 ± 1.55 | 0.102 | 0.87 (0.74–1.03) | 0.105 |
| Birth weight (kg) | 3.14 ± 0.49 | 3.23 ± 0.38 | 0.090 | 1.01 (0.10–1.02) | 0.197 |
| Delivery mode | |||||
| Vaginal | 115 (65.7) | 84 (56.4) | 0.085 | reference | NA |
| Cesarean | 60 (34.3) | 65 (43.6) | 0.77 (0.45–1.32) | 0.337 | |
| Feeding | |||||
| Formula feeding | 41 (23.4) | 77 (51.7) | <0.001 | reference | NA |
| Breast feeding | 84 (48.0) | 31 (20.8) | 2.27 (1.19–4.34) | 0.012 | |
| Mix feeding | 50 (28.6) | 41 (27.5) | 0.38 (0.20–0.73) | 0.060 | |
| Maximum TSB (µmol/L) | 275.5 (184.0–368.8) | 68.1 (39.7–114.9) | <0.001 | NA | NA |
| G6PD deficiency | 6 (3.4) | 0 (0) | 0.033 | 2.48 (0) | 0.999 |
| UGT1A1*6 (c.211G > A) | |||||
| G/G | 72 (41.1) | 117 (78.5) | <0.001 | reference | NA |
| G/A | 82 (46.9) | 31 (20.8) | 4.43 (2.53–7.74) | 0.000 | |
| A/A | 21 (12.0) | 1 (0.7) | 63.10 (5.30–751.63) | 0.001 | |
Data are presented as n (%), mean ± standard deviation, or median (95% Confidence Interval). NA, not applicable; OR, odds ratio.